Skip to content
Research/Peptides/Epithalon (Epitalon)

Epithalon (Epitalon)

Synthetic tetrapeptide bioregulator derived from pineal gland extract. Activates telomerase, extends telomeres, regulates melatonin production, antioxidant. Sequence: Ala-Glu-Asp-Gly.

Intelligence Profile

Safety Profile

Evidence limitation: The safety profile of Epithalon (Epitalon) is severely limited by a lack of human clinical trials and standardized safety studies. All available evidence comes from in vitro and animal studies, making it impossible to establish a comprehensive safety profile for human use.

Known Side Effects

No documented human side effects are available in the scientific literature. The retrieved studies focus primarily on biological mechanisms and effects in laboratory settings rather than safety monitoring in human subjects.

Contraindications

No established contraindications exist due to the absence of human clinical data. Without proper clinical trials, it is impossible to identify specific populations or conditions where Epithalon should be avoided.

Drug Interactions

No drug interaction data is available from the reviewed evidence. The potential for interactions with medications, supplements, or other treatments remains unknown.

Populations That Should Avoid Use

Given the complete absence of human safety data, the following populations should exercise extreme caution or avoid use entirely:

  • Pregnant and breastfeeding women
  • Children and adolescents
  • Individuals with chronic medical conditions
  • Patients taking prescription medications
  • Immunocompromised individuals

Critical Safety Gaps

The evidence reveals significant safety knowledge gaps:

  • No dose-response safety studies
  • No toxicity assessments in humans
  • No long-term safety monitoring
  • No standardized manufacturing or purity requirements
  • No regulatory oversight for human use

Disclaimer: This information is for educational purposes only and does not constitute medical advice. Consult with a healthcare provider before considering any experimental treatments. Epithalon is not approved by regulatory agencies for human therapeutic use.

Recommendation

The lack of human clinical trials and safety studies makes it impossible to recommend safe use of Epithalon. Any consideration of this compound should involve consultation with qualified medical professionals who can assess individual risk factors.

Free account required

Safety profile requires a free AXIFI account to access clinical data, safety profiles, and research papers.